mycin has the advantage of being highly effective against tionship with vancomycin-resistant enterococcal (VRE) colonigram-positive organisms, including those resistant to zation is not established.
Methods. During a two-year prospective cohort study, recmethicillin, and of having an extended duration of action tal swabs obtained from patients at the start and finish of the in end-stage renal disease. Unfortunately, its increased study period and during interim hospitalizations were cultured use has been associated with a dramatic increase in hospifor VRE. 
tal-acquired infections with vancomycin-resistant enter-

METHODS
higher than in those not colonized with VRE (P ϭ 0.005).
Conclusions. VRE colonization is a relatively common and
Study design
underrecognized problem among chronic dialysis patients. It
In December of 1996, we conducted a cross-sectional is strongly and independently associated with the outpatient use of vancomycin, which should be avoided whenever possible.
prevalence study of VRE colonization in our outpatient dialysis center, a freestanding unit located in East Baltimore (MD, USA). Using a standardized protocol, peri-1 Drs. Atta and Eustace contributed equally to this study.
rectal swabs (culturette; Becton Dickinson Microbiology system, Cockeysville, MD, USA) were obtained from all cultured for VRE colonization, as part of routine hospital time of study entry (December 1996) until the time of their first positive VRE rectal culture or until the last practice. Standard infection control measures in the dialysis unit included the use of universal precautions and recorded negative culture either at the end of the study or prior to the subject exiting the cohort. Patients exited the cleaning of all dialysis equipment and the dialysis chair between uses with 2% bleach solution. No specific the cohort prior to study's termination due to transplantation, transfer to another dialysis unit, or patient procedures were in place for dialyzing patients with a history of VRE infection or colonization. In-hospital death. Patients who had no repeat rectal culture during the course of the study and whose follow-up VRE status management included the use of gowns and gloves and the isolation or cohorting of known VRE colonized or was thus unknown were, by necessity, excluded from the primary analysis. Patients who had a positive VRE rectal infected patients. These infection control measures were unchanged over the period of the study. At the end of the swab obtained within 48 hours of hospitalization were assumed to have had VRE colonization prior to hospitalstudy period (December 1998), we conducted a second cross-sectional prevalence study of VRE rectal colonizaization and did not have this last hospitalization counted among their exposure data. As the duration of followtion in all surviving cohort members.
up was different for different subjects, exposure data Outcome ascertainment were expressed in terms of a subject's average exposure per year. Patients were defined as being colonized with VRE only if a cultured rectal swab grew VRE without clinical Primary analysis infection. Rectal swabs were cultured using an identical technique throughout the study period. In brief, speciIn the primary analysis, the effects of vancomycin administered in the chronic dialysis unit were studied sepamens were plated on agar appropriate for each body site and on selective trypticase soy agar media containing rately from that administered within the hospital. The 5% sheep's blood, 10 g/mL vancomycin, and 8 g/mL influence of topical antimicrobial preparations and of progentamicin. Colonies consistent with enterococcus, which phylactic use of cotrimoxazole among HIV patients-on hydrolyze PYR and were gram positive, were speciated which we had incomplete data-was not examined. A using motility, pigment production, and 10% lactose subgroup analysis was, however, performed excluding tests. Final speciation occurred according the scheme of HIV seropositive patients. Facklam and Collins [19] . Vancomycin susceptibility was Statistical methods tested using agar dilution technique and concentrations of vancomycin of 1, 2, 4, 16, and 64 g/mL. If the organOutlying values for the distribution of each variable ism had a minimal inhibitory concentration (MIC) of were identified using boxplots, and their validity was greater than 16 but less than 64, the E test was used to checked against the original clinical record. The VREconfirm according to the National Committee for Clinipositive and -negative groups were compared using the cal Laboratory Standards [20] .
Mann-Whitney U test for continuous and the Fisher's exact test for categorical data. The association of outpaExposure assessment tient vancomycin use with the development of VRE was Baseline demographic information and clinical characexamined using unconditional logistic regression. The teristics of the participating subjects were abstracted influence of individual potential confounders was examfrom the patients' medical records. The dose of vancomyined, one at a time, in separate logistic regression analycin, as well as any additional antibiotics, administered ses. Because of the limited available sample size, more or prescribed in the dialysis unit was obtained from dialextensive regression modeling was not attempted. Paysis unit records. These antibiotics were prescribed actient survival was examined using the Kaplan-Meier cording to the discretion of the attending physician and method and compared using the log rank test. Patients without use of standing orders. In-patient antibiotic use were censored at the time of transplantation or at loss was obtained from the hospital's pharmacy record, and to follow-up. For all analyses, a type I error rate of 0.05 details regarding the in-patient hospital stay and intenwas used. Statistical analysis was performed using SPSS sive care unit admissions were obtained from the Johns software, version 7.5 (Chicago, IL, USA). Hopkins Hospital case-mix database, a database that records the duration and location of patients' stay in the RESULTS hospital. Information on orally prescribed antibiotics was One hundred twenty-four of the 147 patients (84.4%) checked by cross-referencing data from the hospital outattending our dialysis unit in December 1996 agreed patient pharmacy. As this pharmacy delivers medicine to participate in the study. Seventy-four patients were directly to the dialysis unit, it is widely, although not treated with hemodialysis and the remaining 50 with exclusively, used by our dialysis patients.
Exposure data were obtained for all patients from the peritoneal dialysis. Ten of the 124 (8%) patients were of VRE with an odds ratio (95% CI) of 1.23 (1.05, 1.44). This association remained significant following adjustment in separate analyses for the main potential confounders, as shown in Table 3 . This odds ratio for the colonized with VRE when initially cultured (1996) and are not entered into the follow-up cohort. This result association between outpatient vancomycin use and VRE was perceived as being similar to that reported by others colonization was reduced in only three of these analyses, [3, 15-18] and did not lead to any formal change in as compared with the unadjusted odds ratio (1.23). In the use of vancomycin in our unit. Twenty-four of the each case, however, outpatient vancomycin continued to remaining patients initially without VRE were not anaexert a significant and independent effect. Adjustment lyzable, as they had no subsequent VRE culture, and thus for the other potential confounders resulted in either their follow-up VRE status was unknown. One patient no effect or a slight increase in this odds ratio. When underwent renal transplantation. Four transferred to anoutpatient vancomycin was simultaneously adjusted for other dialysis unit, and 15 died before the VRE screen average duration of hospital stay and either inpatient at the end of the study. An additional four patients revancomycin dose or number of hospitalizations, the assomained within the cohort but declined to undergo repeat ciation between outpatient vancomycin (g per year) and VRE screening at the end of follow-up. In comparison VRE colonization continued to be significant, with an to the analyzable group, these 24 patients were older (P ϭ odds ratio of 1.29 (1.07, 1.57, P ϭ 0.007) and 1.22 (1.03, 0.03) and were more likely to be Caucasian (P ϭ 0.003).
1.45, P ϭ 0.02), respectively. More extensive regression VRE incidence rate modeling was not undertaken because of the small number of available cases (N ϭ 16). Repeat analyses using The 90 analyzable patients contributed a total of 157.2 combined inpatient and outpatient vancomycin dose and years of follow-up, with a mean duration of follow-up a subgroup analysis excluding HIV seropositive subjects per subject of 1.75 years. Sixteen incident cases of VRE revealed similar significant results as that of the primary rectal colonization were detected over the course of the study, an incidence rate of 1 case per 9.83 patient years analysis (data not shown). of follow-up.
Clinical VRE infection Of the 90 patients, only 70 patients underwent repeat VRE screening at the end of the study, of whom 6 paOver the course of follow-up, 6 out of 16 (37.5%) tients (8.6%) grew VRE. Two of these patients had their VRE colonized patients developed an overt infection VRE status established previously during prior hospitalrelated to VRE, including one surgical site infection, one izations; however, the VRE colonization status of the urinary tract infection, one episode of peritonitis, and remaining four subjects had been unknown to the dialysis three cases of VRE bacteremia, confirmed in at least staff.
two blood culture bottles. Ten of the 90 patients (11.0%), whose follow-up VRE status was known died over the Determinants of VRE colonization course of the study. Six deaths occurred among the 74 The 90 patients received a total of 403 g of intravenous patients (8.0%) who did not grow VRE, 4 among the vancomycin, 73% of which was administered in the out-16 patients (25%) who grew VRE, including 2 of the 3 patient dialysis unit. There was no significant difference bacteremic patients. Survival in the VRE colonized in the baseline demographic characteristics, the proporgroup was significantly worse than for the noncolonized tion of patients with HIV infection, or diabetes between patients who grew and did not grow VRE (Table 1 ). The group (P ϭ 0.005; Fig. 1 ). ICU is intensive care unit. a P value for association of out-patient vancomycin use with VRE colonization post-adjustment for specified variable
DISCUSSION
In the 11 years since it was first described, VRE has become a global health concern [21] . The excretion of Our study is the first, to our knowledge, to define the VRE has been shown to dramatically increase following incidence of detectable VRE colonization in a cohort of exposure to vancomycin [22] . The unrestricted and rapid outpatient dialysis subjects. In both our 1996 and 1998 increase in the use of vancomycin over the last two deprevalence studies, we found comparable prevalence racades has been implicated in the rapid spread of VRE. tios (8 and 8.5%) to that described in other cross-sectional
In one center, the amount of vancomycin prescribed instudies. However, the calculated incidence ratio per year creased 20-fold in the period between 1981 and 1991 [23] . was higher than either of these two point prevalence
The Centers for Disease Control and Prevention has estimates. In keeping with this observation, we detected specifically advised that vancomycin should not be used a decreased survival in the VRE colonized as compared for prophylactic or empiric therapy or for reasons of with the noncolonized subjects; however, in this data set dosing convenience when alternative treatment options we cannot determine whether this association is in any way causal in nature.
are available. In response, the Ad Hoc Committee on tion-control practices both within the dialysis unit and hospital and the degree of patient comorbidity, also undoubtedly influence the background incidence of VRE, although an analysis of these influences was beyond the scope of our study. The potential influence of dialysis practices on the development of VRE is consistent with the observations that one of the first reported outbreaks of VRE in 1988 occurred in a dialysis unit [16] , that in one study in a single year, from 1995 to 1996, the percentage of American hemodialysis facilities reporting treatment of VRE colonized patients jumped from 17 to 21% [26] , and that chronic dialysis patients represented 12 to 22% of cases of VRE in three large, separate hospitalbased studies [26] . Finally, the observation that five of the seven recently described patients infected with S. aureus with intermediate susceptibility to vancomycin these patients are at a high risk of developing resistant organisms, including those more virulent than enterococci. In addition, considering that only two of the six patients in our cohort who were colonized with VRE in the Treatment of Peritonitis in 1996 changed its recomthe follow-up 1998 prevalence study had their VRE stamendations regarding the empiric treatment of peritonitus previously known to the dialysis staff suggests that tis. Many nephrologists, however, have failed to adopt the effective surveillance of VRE carriage may require these recommendations. In part, this is because of limited formal regular screening programs, as are routinely conalternatives in the treatment of methicillin-resistant Staphducted in other high-risk areas such as in intensive care ylococcus aureus (MRSA) infections and in part because units [4] . much of the literature to date regarding VRE colonizaWe demonstrate a clinically and statistically significant tion has been based on patients hospitalized in intensive independent association between outpatient vancomycin care units or oncology centers [24] , and the applicability use and the development of VRE, a finding in agreement of these studies to the outpatient dialysis setting is uncerwith several studies examining the determinants of VRE tain.
infection in hospitalized patients [21, 24, [27] [28] [29] [30] . These Several studies to date have examined the prevalence data clearly call into question the long-term safety of the of VRE in dialysis populations [2, 3, 15, 17, 18] and have ongoing widespread use of vancomycin in dialysis patients. been perceived as offering reassurance that the continued They further underscore the need to reduce the incidence widespread use of vancomycin in these patients has not of dialysis-associated infections, such as by decreasing been associated with increased rates of developing VRE. the use of hemodialysis catheters [31] , and the developMore recently, Roghmann et al studied 168 dialysis pament of alternative effective antimicrobials for the treattients and found a VRE prevalence of 9.5% [15] . Howment of MRSA. In situations in which there is high backever, the cross-sectional nature of these studies leads ground prevalence of MRSA, the initial use of empiric them to be susceptible to incidence-prevalence bias [25] .
vancomycin therapy for suspected infections may be warThat is, if VRE infection is associated with decreased ranted. However, confirmation of a methicillin-susceptisurvival, then a high incidence rate will not necessarily ble organism should prompt the rapid conversion to an result in a high prevalence rate. Thus, cross-sectional alternative antimicrobial regimen. In hemodialysis, cefastudy designs offer little actual reassurance regarding the zolin when administered postdialysis has been shown to effect of dialysis-associated antibiotic practices on the maintain therapeutic levels for up to 72 hours and thus risk of developing VRE.
avoid the need for supplemental dosing between dialysis This high incidence rate for developing VRE raises sessions [32] . The efficacy of cefazolin in peritoneal dialthe possibility that practices within dialysis units may be ysis patients is, however, less clear [1, 2, 33]. a major driving force in the development and spread of Several important limitations exist regarding our cur-VRE, especially given the relatively better survival of rent study. Twenty-one percent of our original study dialysis patients as compared with many intensive care cohort was excluded because a follow-up VRE surveilunit patients. Our study confirms the significant contribulance culture was not available. The ascertainment of tion of outpatient vancomycin use in the development VRE status during the study was not uniform, being dependent on screening performed during hospitalizaof this high incidence rate. Other factors, including infec-
